Beth Kutscher’s “The Long Reach of Medicine,” the author discusses the booming growth of International Telemedicine in U.S. hospitals. She says, “New technology has created an explosion in demand for international telemedicine, especially in fields such as radiology and pathology that lend themselves to virtual care.”
From robotic assistance to check on a patient with congenital heart defect, to providing education and training, it is no wonder that International Telemedicine has become a strong interest for doctors and patients around the world.
Read more about this interesting article by clicking here.
Not only does Telemedicine breaks down international barriers, but also helps to care for astronauts in space. During these long months, it helps with preventative, diagnostic, and therapeutic care.
Click here to learn more about how NASA uses Telemedicine for astronauts in space.
Ultimately, there is no doubt that International Telemedicine is changing health care. With stronger and smarter technology, more doctors and patients are turning to electronic means to deliver healthcare. Benefits include patient convenience, potential cost savings, ease of prescription refills, and more frequent communication between the doctor and the patient.
Learn more about virtual doctor visits by clicking here.
In Loving Memory of Dr. Stephen Podolsky
It is with great sadness that we inform you of the passing of Dr. Stephen Podolsky, Endocrinologist at New England Allergy, on July 17, 2017.
Dr. Podolsky was the beloved husband of Irina (Lioubarskaia Podolsky) and devoted father of Angelina, Karen and Andrew.
Each one of us not only grieves at the passing of such a tremendous and talented individual, but also for the loss his family suffers.
Dr. Podolsky was such an extraordinary person and this is truly a great loss to New England Allergy. He will deeply missed by everyone whose lives he touched. Nevertheless, let us remember Dr. Podolsky each time with a smile upon our faces. Our thoughts and well wishes go out to his family and friends.
Donations in Dr. Podolsky’s memory may be made to:
Holy Epiphany Russian Orthodox Church
963 South St.
Roslindale, MA 02131
St. Andrew Ukranian Orthodox Church
24 Orchard Hill Road
Jamaica Plain, MA 02130
NEW ENGLAND ALLERGY AUGUST BLOG
AUVI Q IS BACK
THE POCKET SIZED EPINEPHRINE AUTOINJECTOR alternative to the EpiPen is back on the market.
It sells at considerably less than the alternative-generic or brand name, and for commercially insured patients special company coupons cover the patient’s copays. Contact your local AUVI Q representative for details.
WHERE TO FIND THE POLLEN COUNT AND WHY IT MATTERS
HIGH POLLEN COUNTS CAUSE SYMPTOMS ACUTELY IN THOSE ALLERGIC to the pollen in the outside and inside air.
If a patient is on allergy shots for that pollen and is free of symptoms when the pollen count is high, it can reasonably be deduced that the patient is improving as a result of the injections.
If the patient continues to suffer when counts are high, then further attention is necessary.
If the patient is planning to travel to an area of the country where the pollen he or she is allergic to is high, there is an opportunity to provide prophylactic measures including additional medications as necessary.
If a patient is prescribed medications to prevent allergy symptoms and there are no symptoms when the pollen count is high, it can reasonably be deduced that the medication is sufficient.
There are many other useful applications of the pollen count in diagnosis and treatment of your allergy patients.
POLLEN COUNTS MAY BE ACCESSED FOR THE ENTIRE UNITED STATES BY CONSULTING www.pollen.com and simply INPUTING THE LOCAL AREA CODE.
Of course, adequate allergy testing of the patient to ascertain and quantitate sensitivities as a preliminary measure are essential to these applications.
STINGING INSECT VENOMS ON THE WAY BACK
STINGING INSECT VENOMS are about to become available again. We have been informed that shipments will begin in August. Watch for announcements from ALK ABELLO and Hollister Stier.
NEW ENGLAND ALLERGY JULY BLOG
Several new advances have been made which impinge on allergy practices currently and in the future:
I. DUST MITE TABLETS
ALK-Abelló, Inc. has received FDA approval for dust mite sublingual tablets called Odactra which are available for patients 18 to 65 to address the question of dust mite allergy in those patients who do not desire subcutaneous immunotherapy to this antigen, of those not responding to dust mite containment measures.
II. DUPILUMAB AND ATOPIC ECZEMA
Dupilumab has been FDA-approved, a product of Sanofi and Regeneron, Inc. This is an anti-IL 4 and anti-IL 13 monoclonal antibody, highly effective in treating atopic eczema clearing the skin in up to 50% of patients within a period of 8 to 12 weeks of therapy.
Nucala is an anti-IL 5 antibody which has been developed and released by SmithKline, Inc. The monoclonal antibody is termed mepolizumab and is highly effective TH 2 positive eosinophilic conditions such as allergic asthma.
Cinqair or reslizumab has also been approved by the FDA and is also an anti-IL 5 agent which, in contrast to Nucala, is given by intravenous infusion. This medication works in a manner similar to Nucala and is useful in allergic eosinophilic asthma.
V. XOLAIR AND CHRONIC HIVES
Xolair, which is an anti-IgE monoclonal antibody, has been approved by the FDA for chronic idiopathic urticaria. The mechanism of action is felt to be secondary to binding with IgE antibodies, so that they can no longer attach to the mast cell IgE receptors, and as a result the IgE receptors invaginate and are no longer present on the surface of mast cells to be activated by IgG antibody. Xolair has been very effective in the past for treating severe steroid dependent asthma. Currently the response to common idiopathic urticaria has been dramatic in many cases.
Look for the following services in allergy offices:
- Exhaled nitric oxide or ENO. This allows of the titration of asthma to be brought to the point where there is no active residual pulmonary inflammation.
- Pulmonary oscillometry which is useful in children age 5 and above who can concentrate for a minimum of 17 seconds. Measurements before and after bronchodilator allow for the diagnosis of asthma in this age group.
- Nasal smears for eosinophils which can be performed on patients with nasal congestion to look for eosinophil activity indicative of active allergy.